SCHEMBL273853

SCHEMBL273853

C=CCOC(=O)COC1CCCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
GAA P10253 1/20 0.49
TDP1 Q9NUW8 1/20 0.41
CASP1 P29466 1/20 0.39
TSHR P16473 2/20 0.38
CYP3A4 P08684 1/20 0.36
NPSR1 Q6W5P4 4/20 0.35
MAPT P10636 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
EPHX2 P34913 2/20 0.33
CYP2C19 P33261 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
NAAA Q02083 1/20 0.33
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PKM P14618 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27885694 0.98 ALDH1A1 (0.47) ALDH1A1GAATDP1CASP1TSHR
SCHEMBL30017117 0.81 ALDH1A1 (0.36) ALDH1A1GAATDP1CASP1NPSR1
SCHEMBL3043547 0.80 TDP1 (0.40) ALDH1A1GAATDP1TSHRCYP3A4
SCHEMBL3252087 0.77 KMT2A (0.50) ALDH1A1GAATDP1KMT2ANAAA
SCHEMBL19569796 0.77 KMT2A (0.50) ALDH1A1GAATDP1KMT2ANAAA
SCHEMBL3256401 0.77 KMT2A (0.50) ALDH1A1GAATDP1KMT2ANAAA
SCHEMBL3251414 0.77 KMT2A (0.50) ALDH1A1GAATDP1KMT2ANAAA
SCHEMBL11590287 0.75 ALDH1A1 (0.44) ALDH1A1GAACASP1TSHRCYP3A4
SCHEMBL10448619 0.75 ALDH1A1 (0.44) ALDH1A1GAACASP1TSHRCYP3A4
SCHEMBL11592686 0.75 ALDH1A1 (0.44) ALDH1A1GAACASP1TSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1523 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation GIVAUDAN SA (CH) 2026-03-31 US claimed
EP-4695016-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Givaudan SA (CH) 2026-02-18 EP claimed
EP-4655373-A1 BIODEGRADABLE PERFUME COMPOSITION Givaudan SA (CH) 2025-12-03 EP claimed
WO-2025202258-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2025-10-02 WO claimed
US-20250302728-A1 FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD SYMRISE AG (DE) 2025-10-02 US claimed
EP-4526411-A1 FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD Symrise AG (DE) 2025-03-26 EP claimed
WO-2025051371-A1 A FRAGRANCE PASTILLE SYMRISE AG (DE) 2025-03-13 WO claimed
WO-2025045354-A1 A FRAGRANCE TABLET SYMRISE AG (DE) 2025-03-06 WO claimed
WO-2025045353-A1 A FRAGRANCE POD SYMRISE AG (DE) 2025-03-06 WO claimed
EP-4514477-A1 FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE Firmenich SA (CH) 2025-03-05 EP claimed
US-7196051-B2 Process for the preparation of cyclohexyloxyacetic alkyl esters SYMRISE GMBH & CO. KG (DE) 2007-03-27 US claimed
EP-1318137-B1 Process for the preparation of cyclohexyloxyacetic acid alkyl esters SYMRISE GMBH & CO KG (DE) 2006-05-03 EP claimed
EP-0955035-B1 Method of preventing aged body odor SHISEIDO CO LTD (JP) 2004-09-29 EP claimed
US-6780835-B2 DEODORANT FOR TREATING TEXTILES INCORPORATING SPANDEX QUEST INTERNATIONAL B.V. (NL) 2004-08-24 US claimed
EP-1029032-B1 LAUNDRY TREATMENT PRODUCTS FOR SPANDEX CONTAINING FABRICS UNILEVER PLC (GB) 2004-03-03 EP claimed
US-20030109415-A1 Process for the preparation of cyclohexyloxyacetic alkyl esters SYMRISE AG (DE) 2003-06-12 US claimed
CN-1361817-A Perfume compositions PROCTER & GAMBLE (US) 2002-07-31 CN claimed
EP-1072673-A2 Perfume compositions THE PROCTER & GAMBLE COMPANY (US) 2001-01-31 EP claimed
WO-2001005919-A2 PERFUME COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2001-01-25 WO claimed
EP-0955035-A1 Body odor preventing composition SHISEIDO COMPANY LIMITED (JP) 1999-11-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation CUTA, EXOC1, EXOSC10 ALDH1A1 2581/4885GAA 2113/4885TDP1 1746/4885
US-20030109415-A1 Process for the preparation of cyclohexyloxyacetic alkyl esters FAAH, HAAO, HACL2 ALDH1A1 441/4885GAA 679/4885TDP1 4395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.